Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study

The Lancet Neurology

Volumn 11, Issue 3, 2012, Pages 232-240

  Byrne, Susan ^a,b   Elamin, Marwa ^a,b   Bede, Peter ^a,b   Shatunov, Aleksey ^c   Walsh, Cathal ^b   Corr, Bernie ^a   Heverin, Mark ^a   Jordan, Norah ^b   Kenna, Kevin ^b   Lynch, Catherine ^a   McLaughlin, Russell L ^b   Iyer, Parameswaran Mahadeva ^a,b   O'Brien, Caoimhe ^a   Phukan, Julie ^a,b   Wynne, Brona ^a   Bokde, Arun L ^b   Bradley, Daniel G ^b   Pender, Niall ^a   Al Chalabi, Ammar ^c   Hardiman, Orla ^a,b  

^a BEAUMONT HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REPETITIVE DNA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEHAVIOR CHANGE; COGNITION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; IRELAND; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN READING FRAME; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL; SURVIVAL TIME;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CHROMOSOMES, HUMAN, PAIR 9; COGNITION; COHORT STUDIES; DNA REPEAT EXPANSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84857050135     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70014-5     Document Type: Article

References (27)

1. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2011, 83:102-108.
2. Morita M, Al-Chalabi A, Andersen PM, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006, 66:839-844.
3. Van Es MA, Veldink JH, Saris CG, et al. Genome wide association study identifies 19p 13.3 (UNC13A) and 9p 21.2 as susceptibility loci for amyotrophic lateral sclerosis. Nat Genet 2009, 41:1083-1087.
4. Shatunov A, Mok K, Newhouse S, et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 2010, 10:986-994.
5. Laaksovirta H, Peuralinna T, Schymick JC, et al. Chromosome (p21 in amyotrophic lateral sclerosis in Finland: a genome wide association study. Lancet Neurol 2010, 10:978-985.
6. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-254.
7. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p-21 linked ALS-FTD. Neuron 2011, 72:257-268.
8. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008, 79:30-33.
9. Traynor BJ, Codd MB, Corr B, et al. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999, 52:504-509.
10. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011, 76:1263-1269.
11. Browning SR, Browning BL Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 2007, 81:1084-1097.
12. Cole J, Conneally M, Hodes ME, et al. Genetic Family History Questionnaire. J Med Genet 1978, 1:10-18.
13. Ashburner J, Friston KJ Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
14. Hope ACA A simplified Monte Carlo significance test procedure. J Roy Statist Soc 1968, B30:582-598.
15. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999, 31:13-21.
16. Mok K, Traynor BJ, Schymick J, et al. The chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 2012, 33:209.
17. Grace J, Stout JC, Malloy PF Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale. Assessment 1999, 6:269-284.
18. Hardiman O, van den Berg LH, Kiernan MC Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011, 71:639-649.
19. Royall DR, Lauterbach EC, Cummings JL, et al. Executive control function: a review of its promise and challenges for clinical research. J Neurol Neurosurg Psychiatry 2002, 14:377-405.
20. Abrahams S, Goldstein LH, Simmons M, et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 2004, 127:1507-1517.
21. Kaufmann L, Koppelstaetter F, Delazer M, et al. Neural correlates of distance and congruity effects in a numerical Stroop task: An event-related fMRI study. Neuroimage 2005, 15:888-898.
22. Chio A, Vignola A, Mastro E, et al. Neurobehavioural symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol 2010, 10:1298-1303.
23. Neary D, Snowdon JS, Gustafson L, et al. Frontemporal lobar degeneration. A consensus clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
24. Byrne S, Bede P, Elamin M, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011, 12:157-159.
25. Byrne S, Elamin M, Bede P, et al. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. J Neurol Neurosurg Psychiatry 2012, (in press).
26. Gijselinck I, Van Langenhove T, van der Zee J, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 2012, 11:54-65.
27. Cooper-Knock J, Hewitt C, Robin Highley J, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 2012, (in press).